Searched for
KOTAK PHARMA FUND
Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...- Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Red alert: 15 stocks most vulnerable to FII selling as DIIs refuse to step inForeign institutional investors have divested approximately $53 billion from Indian equities since September 2024, leading to significant o...
- Is your portfolio FII-proof? 7 stocks Jefferies says can defy the $53 billion foreign selloffForeign investors have divested $53 billion from Indian equities since late 2024, leading to underperformance against emerging markets. Dom...
- Jio Financial, ITC Hotels and Manappuram Finance among stocks bought and sold by mutual funds in AprilMutual funds injected Rs 30,600 crore into Indian equities in April, with significant buying in ICICI Bank, SBI, and Sun Pharma. Key reduct...
- Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...
- Gold, silver ETFs slip up to 3% as crude surge, weak Iran talks dent sentiment. What should investors do?Gold and silver ETFs declined up to 3% as bullion prices fell sharply amid rising crude oil prices and uncertainty around US-Iran talks. Hi...
- JioBlackRock Flexi Cap Fund exits Swiggy, 20 other stocks; adds ICICI Pru AMC and 9 more in MarchJioBlackRock Mutual Fund’s Flexi Cap Fund exited Swiggy and 20 other stocks in March, while adding ICICI Prudential Asset Management Compan...
- MFs buy large banks, NBFCs, select auto and pharma in FebAs flows into mid- and small-cap thematic funds moderated and valuations remained rich, fund managers were cautious in these segments. Camp...
- Kotak Alt invests Rs 1445 crore for the acquisition of Viatris' API business by Matrix PharmaKotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient (A...
- Kotak Alternate Asset Managers invests Rs 1,445 cr to help Matrix Pharma execute acquisitionKotak Alternate Asset Managers Ltd invested Rs 1,445 crore in Matrix Pharma for acquiring Vaitris' API business, making Matrix the 2nd larg...
- Edelweiss fund to back Matrix Lab founder's buyout of Viatris API bizKotak is lending $150 million (₹1,250 crore) under a mezzanine debt facility to Prasad at 18-20% and arranging an additional $300 million f...
- Kotak Mutual Fund launches Kotak Healthcare FundThe fund aims to generate long-term capital appreciation through investing in a diversified portfolio of healthcare-related stocks in pharm...
- Gland Pharma raises Rs 1944 crore before IPOThe IPO will open from 9 November for subscription and will close on 11 November.
- Stocks that held the fort for 3 best performing PMSes in last one yearBSE benchmark Sensex is down 17 per cent for last three months.
- Money managers turn cautious, value buying emerges in pharmaIn the financial sector, some funds were seen buying Kotak Mahindra Bank and HDFC.
- Kotak Private Equity may exit Rubicon with 3x returnsRubicon Research will also raise primary capital by selling another 20-25% through this round of fundraising that values the company at $20...
Load More
